EXELIXIS INC. revenue breakdown overview

EXELIXIS INC. revenue for the last year amounted to 1.66 B EUR, the most of which — 1.66 B EUR — came from its highest performing source at the moment, Medicines for Difficult-to-treat Cancers, the year earlier bringing 1.51 B EUR. The greatest contribution to the revenue figure was made by United States — last year it brought EXELIXIS INC. 1.49 B EUR, and the year before that — 1.32 B EUR.